Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain

Related Experiment Videos

Insights

Neuropathologic examination of children with acquired immunodeficiency syndrome (AIDS) revealed a distinct CNS disorder. Findings included brain weight reduction, inflammation, and white matter changes, linked to the LAV/HTLV-III virus.

Area of Science:

  • Neuropathology
  • Virology
  • Pediatric Neurology

Background:

  • Acquired immunodeficiency syndrome (AIDS) can manifest with central nervous system (CNS) disorders in children.
  • The human immunodeficiency virus (HIV), previously known as lymphadenopathy-associated virus (LAV) or human T-lymphotropic virus type III (HTLV-III), is the causative agent of AIDS.
  • Progressive encephalopathy is a serious complication in children with AIDS.

Observation:

  • Autopsy findings in 11 children with AIDS and progressive encephalopathy were analyzed.
  • Neuropathologic examination revealed a unique pattern of CNS abnormalities.
  • Patients ranged from 4 months to 11 years old, with most having LAV/HTLV-III antibodies or contaminated blood products.

Findings:

  • Consistent findings included diminished brain weight, inflammatory cell infiltrates, multinucleated cells (including giant cells), vascular calcification, and white matter changes.
  • Inflammatory and vascular lesions were predominantly observed in the basal ganglia and pons.
  • Evidence of LAV/HTLV-III retroviral particles and genome was detected in brain tissue via electron microscopy and hybridization studies.

Implications:

  • These findings characterize a specific neuropathologic disorder associated with pediatric AIDS.
  • The study highlights the direct CNS impact of the LAV/HTLV-III virus.
  • Understanding these neuropathologic changes is crucial for managing pediatric HIV/AIDS patients.

Related Concept Videos